Expression Rate and PAX5 Gene Methylation in the Blood of People Suffering from Gastric Cancer

Authors

  • Mozhdeh Khajeh Haghverdi Department of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.
  • Elham Moslemi Department of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.

DOI:

https://doi.org/10.3889/oamjms.2018.269

Keywords:

Gastric Cancer, PAX5, Real-time PCR, MS PCR, Methylation

Abstract

BACKGROUND: Gastric cancer is one of the most important health issues in the world. Considering the lack of plenty of pre-awarenesses, the survival of gastric cancer is still quite disappointing. Methylation of PAX5 gene promoter is observed in most cancer cells of a human. A study has shown that PAX5 is a new tumoral suppressor in gastric cancer and methylation of the PAX5 promoter is associated with the survival rate of gastric cancer.

AIM: The present research seeks to study the expression rate and methylation of the PAX5 gene in the blood of patients who have gastric cancer to be used as a biomarker in this type of cancer.

MATERIAL AND METHODS: Real-time PCR technique was used to assess expression of PAX5 gene, while the methylation status of PAX5 gene promoter in the blood samples of people who have gastric cancer versus blood samples obtained from normal Iranian population was studied using MS PCR technique.

RESULTS: The final results pointed to the fact that expression of PAX5 in blood samples obtained from those who have gastric cancer is much less than what is observed in normal blood samples. A significant correlation was also observed between expression of this gene and age and promoter methylation rate. The results of methylation also indicated that 28% of PAX5 gene promoters among patients were methylated, while all normal samples were non-methylated.

CONCLUSION: Studying the decrease observed in PAX5 gene expression and the rise in promoter methylation can be utilised as a biomarker to enhance pre-awareness of gastric cancer.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Alberts SR, Cervantes A, Van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Annals of oncology. 2003; 14(Suppl 2):ii31-6. https://doi.org/10.1093/annonc/mdg726 PMid:12810455

Alemán JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014; 146(2):357-73. https://doi.org/10.1053/j.gastro.2013.11.051 PMid:24315827 PMCid:PMC3978703

Foroutan M, Rahimi N, Tabatabaeifar M, Darvishi M, Hashemi M, Hossein-panah F, et al. Clinical features of colorectal cancer in Iran: A 15-year review. J Dig Dis. 2008; 9(4):225-227. https://doi.org/10.1111/j.1751-2980.2008.00351.x PMid:18959595

Balasenthil S, Gururaj AE, Talukder AH, Bagheri-Yarmand R, Arrington T, Haas BJ, Braisted JC, Kim I, Lee NH, Kumar R. Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Research. 2007; 67(15):7132-8. https://doi.org/10.1158/0008-5472.CAN-07-0750 PMid:17671180

Beales IL, Hensley A, Loke Y. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition. World J Gastrointest Pharmacol Ther. 2013; 4(3):69-79. https://doi.org/10.4292/wjgpt.v4.i3.69 PMid:23919219 PMCid:PMC3729870

Beliën JA, Buffart TE, Gill AJ, Broeckaert MA, Quirke P, Meijer GA, Grabsch H. Gross genomic damage measured by DNA image cytometry independently predicts clinical outcome in gastric cancer. DNA copy number profiling of gastric cancer and its clinical implications. 2008:179.

Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, Rakhshani N, Didevar R, Sotoudeh M, Zolfeghari AA, McColl KE. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008; 57(3):298-305. https://doi.org/10.1136/gut.2007.137364 PMid:17965056

Chen FL, Wang XZ, Li JY, Yu JP, Huang CY, Chen ZX. 12-lipoxygenase induces apoptosis of human gastric cancer AGS cells via the ERK1/2 signal pathway. Digestive diseases and sciences. 2008; 53(1):181-7. https://doi.org/10.1007/s10620-007-9841-1 PMid:17522976

Cheng D, Hao Y, Zhou W, Ma Y. Positive association between Interleukin-8-251A> T polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Cancer cell international. 2013; 13(1):100. https://doi.org/10.1186/1475-2867-13-100 PMid:24143859 PMCid:PMC3854499

Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. TRENDS in Genetics. 2002; 18(1):41-7. https://doi.org/10.1016/S0168-9525(01)02594-X

Palmisano WA, Crume KP, Grimes MJ, Winters SA, Toyota M, Esteller M, Joste N, Baylin SB, Belinsky SA. Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. Cancer research. 2003; 63(15):4620-5. PMid:12907641

Liu C, Jiang Z, Deng QX, Zhao YN. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese. Asian Pacific journal of cancer prevention: APJCP. 2014; 15(11):4689-95. https://doi.org/10.7314/APJCP.2014.15.11.4689 PMid:24969905

Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, Shu X, Rong R, Xiong L, Li H, Chan AT. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Cellular and molecular life sciences. 2014; 71(11):2179-92. https://doi.org/10.1007/s00018-013-1485-z PMid:24158497

Deng J, Liang H, Zhang R, Dong Q, Hou Y, Yu J, Fan D, Hao X. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer. Oncotarget. 2014; 5(17):7420. https://doi.org/10.18632/oncotarget.1973 PMid:25277182 PMCid:PMC4202133

Dong X, Wu J, Liang P, Li J, Yuan L, Liu X. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis. Archives of medical research. 2010; 41(2):125-33. https://doi.org/10.1016/j.arcmed.2010.01.001 PMid:20470942

Published

2018-09-19

How to Cite

1.
Haghverdi MK, Moslemi E. Expression Rate and PAX5 Gene Methylation in the Blood of People Suffering from Gastric Cancer. Open Access Maced J Med Sci [Internet]. 2018 Sep. 19 [cited 2024 Mar. 28];6(9):1571-6. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.269

Issue

Section

A - Basic Science